CBT - MGH Center for Women's Mental Health

Cognitive-Behavioral Therapy for the Treatment of Menopausal Hot Flashes: A Pilot Study

Hot flashes are a common and distressing symptom of menopause, affecting approximately 60-70 % of women undergoing the menopausal transition. Several pharmacologic treatments for hot flashes, including hormone replacement therapy (HRT) and some antidepressants, have been shown to reduce the frequency and intensity of hot flashes. However, some women prefer not to use HRT or antidepressants and seek alternative treatments, such as homeopathic or herbal remedies. Many of these alternative treatments have not yet been evaluated for safety or efficacy.

By MGH Center for Women's Mental Health|2015-08-11T15:16:17-04:00September 29th, 2008|Menopausal Symptoms|0 Comments

How to Treat Anxiety Symptoms During Pregnancy

Click here to see an updated version of this post.

By MGH Center for Women's Mental Health|2015-07-28T11:11:38-04:00December 11th, 2007|Psychiatric Disorders During Pregnancy|32 Comments

Cognitive Therapy versus Medication in the Treatment of Depression

Both antidepressant medications and cognitive therapy have been shown to be effective for the treatment of depression; however, the question remains as to whether one treatment is preferred over the other. Subjects enrolled in The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study (men and women with major depression, ages 18-75) were initially treated with citalopram, an SSRI. Those who had unsatisfactory outcomes after initial treatment were eligible for a randomized second-step treatment trial in which they switched to a new treatment (either cognitive therapy or a different antidepressant) or augmented the citalopram regimen with either cognitive therapy or a different antidepressant.

By MGH Center for Women's Mental Health|2015-07-28T11:03:46-04:00November 26th, 2007|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|1 Comment

Paroxetine and Cognitive-Behavioral Therapy (CBT) for the Treatment of Postpartum Depression (PPD)

Postpartum depression (PPD) is relatively common, occurring in about 10 to 15% of women after delivery. Non-pharmacologic interventions, including interpersonal psychotherapy, have been shown to be effective for the treatment of PPD. In addition, several reports have documented the efficacy of selective serotonin reuptake inhibitors (SSRIs) and the serotonin norepinephrine reuptake inhibitor venlafaxine (Effexor). In a recent report, Misri and colleagues have evaluated whether the addition of Cognitive-Behavioral Therapy (CBT) to standard antidepressant treatment improves outcomes in women with postpartum depression and co-morbid anxiety.

By MGH Center for Women's Mental Health|2015-07-21T11:37:31-04:00September 20th, 2004|Postpartum Psychiatric Disorders|0 Comments

Preventing Depression During Pregnancy

Women who take antidepressants for their depression must make a difficult decision when they plan to become pregnant. Should they continue their medication during pregnancy? Or should they stop? Although there is information to support the reproductive safety of at least some antidepressants, most women, understandably concerned about exposing their babies to medication, choose to discontinue their antidepressant during pregnancy.

By MGH Center for Women's Mental Health|2022-01-13T18:09:48-04:00May 6th, 2000|Psychiatric Disorders During Pregnancy|0 Comments